title: A prospective study of the cost-utility of the multichannel cochlear implant.
abstract: BACKGROUND
  Prior clinical studies have indicated that cochlear implantation provides benefits to individuals with advanced sensorineural hearing loss who are unable to gain effective speech recognition with hearing aids.
  
  
  OBJECTIVE
  To determine the cost per quality-adjusted life-year (QALY) for adults receiving multichannel cochlear implants.
  
  
  METHODS
  Prospective 12-month multicenter study using preference-based quality-of-life measures and total cost determinations, comparing profoundly hearing-impaired adult subjects with and without cochlear implants.
  
  
  METHODS
  Hospital-based and patient-resource clinics.
  
  
  METHODS
  Severely to profoundly hearing-impaired adult recipients of a cochlear implant and adults eligible for the device who had not yet received it.
  
  
  METHODS
  Clinical assessment of implant participants included medical and audiologic (speech understanding) data at the time of enrollment, 6 months, and 12 months. All participants' health-utility was assessed at the time of enrollment, 6 months, and 12 months using the Health Utility Index. One-year medical resource utilization and cost data included bills related to implants, patient diaries, charge estimates from clinical sites, and published literature. A decision model was developed to determine cost per QALY.
  
  
  RESULTS
  Of the 84 enrolled adults, 62 (75%) completed the study. Mean health-utility scores at the time of enrollment were identical between groups. The marginal 12-month health-utility gain for implant recipients was 0.20; 90% of this improvement was achieved within 6 months. For patients with a mean 22-year life expectancy, the marginal cost per QALY was $14,670.
  
  
  CONCLUSIONS
  Overall, multichannel cochlear implants significantly improved recipients' performance on measures of speech understanding and ratings of health-utility within 6 months of implantation. The multichannel cochlear implant yielded a very favorable cost per QALY.
authors.affiliation: MEDTAP International, Bethesda, MD 20814, USA. Palmer@MEDTAP.com
authors.forename: C S
authors.initials: CS
authors.lastname: Palmer
authors.forename: J K
authors.initials: JK
authors.lastname: Niparko
authors.forename: J R
authors.initials: JR
authors.lastname: Wyatt
authors.forename: M
authors.initials: M
authors.lastname: Rothman
authors.forename: G
authors.initials: G
authors.lastname: de Lissovoy
mesh_terms: D000328:Adult; D000368:Aged; D019929:Cochlear Implantation / Q000191:economics*; D003054:Cochlear Implants / Q000191:economics*; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D003638:Deafness / Q000534:rehabilitation / Q000601:surgery; D003661:Decision Support Techniques; D005260:Female; D005500:Follow-Up Studies; D017048:Health Care Costs; D006295:Health Resources / Q000191:economics / Q000706:statistics & numerical data; D006304:Health Status; D006801:Humans; D008017:Life Expectancy; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D011446:Prospective Studies; D011474:Prosthesis Design; D011788:Quality of Life; D019057:Quality-Adjusted Life Years; D013067:Speech Perception / Q000502:physiology